National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 5/7/2021 release of VAERS data:

Found 86 cases where Vaccine is FLU(H1N1) or FLU3 or FLU4 or FLUA3 or FLUA4 or FLUC3 or FLUC4 or FLUN(H1N1) or FLUN3 or FLUN4 or FLUR3 or FLUR4 or FLUX or FLUX(H1N1) or H5N1 and Patient Died and Appearance Date from '2020-09-01' to '2021-02-28'



Case Details

This is page 9 out of 9

Result pages: prev   1 2 3 4 5 6 7 8 9


VAERS ID: 884471 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2020-09-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUX: INFLUENZA (SEASONAL) (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Adverse event following immunisation, Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: COSA2020SA251359

Write-up: person who apply it and killed him. One more step to death; Initial information received on 14-Sep-2020 regarding an unsolicited valid serious case from a non-health care professional. This case involves a male patient (age not reported) who died after receiving INFLUENZA VACCINE, it was reported that "a person who apply it and killed him. one more step to death (Death)". Medical history, medical treatment(s), vaccination(s), family history and concomitant medication(s) were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (brand name not reported) (lot number and expiration date were not reported) via unknown route in unknown administration site as prophylactic vaccination. On an unknown date, the patient died (death) (Unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant as it led to death of the patient. Comment made by other user as, "I met a person who apply it and killed him. One more step to death". No laboratory data reported. It was not reported if the patient received a corrective treatment. Date of death was not reported. It was unknown at the time of reporting if an autopsy was done and the cause of death was not reported. Reported that "Drug related adverse event: yes". There will be no information available for the batch number for this case (Additional information was not obtained during immediate follow because the reporter did not provide contact information). Sender''s Comments: A case was reported, which involves a patient of unknown demographics who died after vaccination with INFLUENZA VACCINE (unknown manufacturer).Time to onset was unknown for event death. Additional information regarding patient''s relevant medical history, health condition at time of vaccination, concomitant medication and Laboratory tests, autopsy results for cause of death is needed for complete assessment of the case. Reported Cause(s) of Death: death nos


VAERS ID: 886926 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-09-21
Onset:2020-09-21
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2020-10-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUX: INFLUENZA (SEASONAL) (NO BRAND NAME) / UNKNOWN MANUFACTURER Q20200604 / UNK - / -
PPV: PNEUMO (PNEUMOVAX) / MERCK & CO. INC. S020307 / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: CN0095075132009CHN009056

Write-up: death; This spontaneous report was received from an unspecified reporter via Center for Disease Control and Prevention (CDC) concerning to a 87 years old male patient. The patient''s medical history, concurrent conditions and concomitant therapies were not provided. On 21-SEP-2020, he was vaccinated with one dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX) (lot#S020307, expiry date: 24-JAN-2021) and influenza virus vaccine (unspecified) (lot# Q20200604, expiry date: 08-JUN-2021) (strength, dose and route were not provided for any suspect therapy). On the same date before 6pm, he died. The cause of death as well as was if an autopsy was performed were unknown. The causal relationship between the patient''s death and the suspect therapy was not provided. Lot investigation was initiated due to patient''s death.


VAERS ID: 890335 (history)  
Form: Version 2.0  
Age: 92.0  
Sex: Male  
Location: Foreign  
Vaccinated:2019-11-04
Onset:2020-07-01
   Days after vaccination:240
Submitted: 0000-00-00
Entered: 2020-10-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUA3: INFLUENZA (SEASONAL) (CHIROMAS) / NOVARTIS VACCINES AND DIAGNOSTICS 9153B1A / UNK - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: COVID-19 pneumonia, Death
SMQs:, Infective pneumonia (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2020-07-03
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: None
Allergies:
Diagnostic Lab Data:
CDC Split Type: ESSEQIRUS202005215

Write-up: Pneumonia from COVID-19; This spontaneous case was retrieved on 15-Oct-2020 from regulatory reference number: ES-AEMPS-679931), reported by a pharmacist and concerned a 92-year-old, male patient. The patient''s medical history and concomitant medications were not reported. On 04-Nov-2019, the patient was vaccinated with Chiromas (TIV) (influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, MF59; dose reported as single dose, route of administration: intramuscular and anatomical location: not reported) as flu vaccination. The batch number reported was 9153B1A. On 01-Jul-2020, seven months and 27 days after receiving Chiromas (TIV), the patient developed pneumonia from COVID-19. On 03-Jul-2020, the patient died due to pneumonia from COVID-19. It was unknown if the autopsy was done. The reporter did not provide causality assessment. The event of ''COVID-19 pneumonia'' was considered serious due to the criterion of medical significance and fatal outcome by a Physician within Seqirus'' Pharmacovigilance and Risk Management Department. Company comment: The 92-year-old patient was administered suspect product, Chiromas (TIV). Reportedly, approximately eight months after vaccination, the patient developed COVID-19 pneumonia. Chronology is unsuggestive. It was reported that the patient died due to COVID-19 pneumonia. It was not reported whether autopsy was performed. The patient''s medical history and concomitant medications were not reported. Considering biological and chronological implausibility, causal role of the suspect vaccine is assessed as not related.; Sender''s Comments: The 92-year-old patient was administered suspect product, Chiromas (TIV). Reportedly, approximately eight months after vaccination, the patient developed COVID-19 pneumonia. Chronology is unsuggestive. It was reported that the patient died due to COVID-19 pneumonia. It was not reported whether autopsy was performed. The patient''s medical history and concomitant medications were not reported. Considering biological and chronological implausibility, causal role of the suspect vaccine is assessed as not related. ES-AEMPS-630523:; Reported Cause(s) of Death: Pneumonia from COVID-19


VAERS ID: 890336 (history)  
Form: Version 2.0  
Age: 75.0  
Sex: Male  
Location: Foreign  
Vaccinated:2019-11-26
Onset:2020-07-02
   Days after vaccination:219
Submitted: 0000-00-00
Entered: 2020-10-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUA3: INFLUENZA (SEASONAL) (CHIROMAS) / NOVARTIS VACCINES AND DIAGNOSTICS 9153A1A / UNK - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: COVID-19 pneumonia, Death
SMQs:, Infective pneumonia (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2020-07-03
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: None
Allergies:
Diagnostic Lab Data:
CDC Split Type: ESSEQIRUS202005216

Write-up: Pneumonia from COVID-19; This spontaneous case from Spain was retrieved on 15-Oct-2020 from EudraVigilance (regulatory reference number: ES-AEMPS-679932), reported by a pharmacist and concerned a 75-year-old, male patient. The patient''s medical history and concomitant medications were not reported. On 26-Nov-2019, the patient was vaccinated with Chiromas (TIV) (influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, MF59; dose: single dose, route of administration: intramuscular and anatomical location: not reported] as flu vaccination. The batch number reported was 9153A1A. On 02-Jul-2020, seven months and six days after receiving Chiromas (TIV), the patient developed pneumonia from COVID-19. On 03-Jul-2020, the patient died due to the pneumonia from COVID-19. It was unknown if the autopsy was done. The reporter did not provide causality assessment. The event of ''COVID-19 pneumonia'' was considered serious due to the criterion of medical significance and fatal outcome by a Physician within Seqirus'' Pharmacovigilance and Risk Management Department. Company comment: A 75-year-old, male patient was administered the suspect product, Chiromas (TIV). The patient developed COVID-19 infection, seven months and six days after vaccination. Reportedly, the patient died due to COVID-19 infection. It was not reported whether autopsy was performed. The patient''s medical history and concomitant medications were not reported. Considering biological implausibility, causal role of the suspect vaccine is assessed as not related.; Sender''s Comments: A 75-year-old, male patient was administered the suspect product, Chiromas (TIV). The patient developed COVID-19 infection, seven months and six days after vaccination. Reportedly, the patient died due to COVID-19 infection. It was not reported whether autopsy was performed. The patient''s medical history and concomitant medications were not reported. Considering biological implausibility, causal role of the suspect vaccine is assessed as not related. ES-AEMPS-630523:; Reported Cause(s) of Death: Pneumonia from COVID-19


VAERS ID: 891171 (history)  
Form: Version 2.0  
Age: 75.0  
Sex: Female  
Location: Foreign  
Vaccinated:2019-11-28
Onset:2020-03-20
   Days after vaccination:113
Submitted: 0000-00-00
Entered: 2020-10-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUA3: INFLUENZA (SEASONAL) (CHIROMAS) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: COVID-19, Death
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2020-04-16
   Days after onset: 27
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data:
CDC Split Type: ESSEQIRUS202005214

Write-up: COVID-19; This spontaneous case was retrieved on 15-Oct-2020 from Regulatory Authority (reference number: ES-AEMPS-679917), reported by pharmacist to and concerned a 75-year-old, female patient. The patient''s medical history and concomitant medications were not reported. On 28-Nov-2019, the patient was vaccinated with CHIROMAS (TIV) [influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, mf59; route of administration: intramuscular, dose reported as one, anatomical location: not reported] for flu vaccination. The batch number was not reported. On 20-Mar-2020, three months and 21 days after vaccination, the patient developed COVID-19. On 16-Apr-2020, the patient died. Cause of death was COVID-19. It was unknown if autopsy was done. The reporter did not provide causality assessment to CHIROMAS (TIV). The event of ''COVID-19'' was considered serious due to the criterion of medical significance and fatal outcome by a Physician within and Risk Management Department. Company comment: A 75-year-old, female patient was administered the suspect product, CHIROMAS (TIV). The patient developed COVID-19 infection, three months and 21 days after vaccination. Reportedly, the patient died due to COVID-19 infection. It was not reported whether autopsy was performed. The patient''s medical history and concomitant medications were not reported. Considering biological implausibility, causal role of the suspect vaccine is assessed as not related. Sender''s Comments: A 75-year-old, female patient was administered the suspect product, CHIROMAS (TIV). The patient developed COVID-19 infection, three months and 21 days after vaccination. Reportedly, the patient died due to COVID-19 infection. It was not reported whether autopsy was performed. The patient''s medical history and concomitant medications were not reported. Considering biological implausibility, causal role of the suspect vaccine is assessed as not related. ES-AEMPS-630523: Reported Cause(s) of Death: COVID-19


VAERS ID: 897458 (history)  
Form: Version 2.0  
Age: 87.0  
Sex: Female  
Location: Foreign  
Vaccinated:2020-10-26
Onset:2020-10-26
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2020-11-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) / SANOFI PASTEUR UJ449AB / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cardiac arrest, Condition aggravated, Death, Loss of consciousness, Presyncope, Seizure
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Convulsions (narrow), Acute central respiratory depression (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Respiratory failure (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2020-10-26
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Heart disease, unspecified
Allergies:
Diagnostic Lab Data:
CDC Split Type: CASA2020SA303409

Write-up: vasovagal reaction to the injection; Cardiac arrest; convulsions; quickly lost consciousness; Initial information was received on 27-Oct-2020 regarding an unsolicited valid serious case from the other health care professional. This case involves a 87-years-old female patient who quickly lost consciousness (loss of consciousness), cardiac arrest, convulsions (seizure) and vasovagal reaction to the injection (presyncope), while she received INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE]. Patient had underlying heart conditions. Concomitant medication, medical treatments, vaccinations and family history were not provided. On 26-Oct-2020, the patient received a dose of 0.5 mL suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE Suspension for injection in pre-filled syringe (lot number: UJ449AB, expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination. On 26-Oct-2020, the patient had cardiac arrest, quickly lost consciousness (loss of consciousness) and convulsions (seizure) (serious events) same day following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. These events were assessed as medically significant and cardiac arrest was leading to death. Coroner confirmed that it was not caused by the vaccine but a vasovagal reaction to the injection (presyncope) occurred (unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. It was reported that 25 other residents received the same vaccine but there were no adverse reactions. Details of laboratory data were not reported. It was not reported if the patient received any corrective treatment. It was unknown if an autopsy was done. The cause of death was reported as Cardiac arrest. Additional information was received on 12-Nov-2020. New event cardiac arrest was added. Cause of death was updated.; Sender''s Comments: Additional information received on 12-Nov-2020 changes the previous assessment of the case. This case concerns a 87-year-old female patient who had cardiac arrest, loss of consciousness, seizure, and presyncope after vaccination with FLUZONE HIGH DOSE. Patient had underlying heart conditions (unspecified). It was reported that Coroner confirmed that it was not caused by the vaccine but a vasovagal reaction to the injection. The cause of death was cardiac arrest. Further information regarding autopsy result and lab tests ruling out alternate etiologies were not reported. Based upon the reported information, the role of the suspect vaccine cannot be assessed.; Reported Cause(s) of Death: cardiac arrest


Result pages: prev   1 2 3 4 5 6 7 8 9

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=9&VAX[]=FLU(H1N1)&VAX[]=FLU3&VAX[]=FLU4&VAX[]=FLUA3&VAX[]=FLUA4&VAX[]=FLUC3&VAX[]=FLUC4&VAX[]=FLUN(H1N1)&VAX[]=FLUN3&VAX[]=FLUN4&VAX[]=FLUR3&VAX[]=FLUR4&VAX[]=FLUX&VAX[]=FLUX(H1N1)&VAX[]=H5N1&DIED=Yes&REPORT_YEAR_LOW=2020&REPORT_MONTH_LOW=09&REPORT_YEAR_HIGH=2021&REPORT_MONTH_HIGH=02


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166